Atlantic Congratulates Immunotherapy Researcher Dr. James P. Allison, 2018 Winner of Nobel Prize in Physiology or Medicine
Resource type: News
The Atlantic Philanthropies |
The Atlantic Philanthropies and Founder Chuck Feeney congratulate James P. Allison, Ph.D., director of the Cancer Research Institute (CRI) Scientific Advisory Council, for winning the 2018 Nobel Prize in Physiology or Medicine.
Dr. Allison was chosen for this year’s Nobel Prize, along with Dr. Tasuku Honjo, M.D., Ph.D., of Kyoto University School of Medicine for their groundbreaking work in cancer immunotherapy, which has revolutionized cancer treatment over the past decade.
“Dr. Allison’s discoveries have been a game-changer in cancer treatment, saved lives and offer hope to millions with cancer,” said Christopher G. Oechsli, President and CEO The Atlantic Philanthropies. “We’re proud to have been an early supporter of immunotherapy research at CRI promoted by the late Lloyd K. Old and carried forward by Dr. Allison.”
Atlantic applauds Dr. Allison for his outstanding work in advancing the field of immunotherapy.
Cancer Research Institute is an Atlantic grantee.
- Read CRI’s announcement
- Read this report about Atlantic’s over $1 billion in investments to advance cancer research around the world, including immunotherapy research at CRI